Jump to Navigation
Malaysia Airlines Flight MH370 may have turned back...
Bitcoin pits gold bugs vs 'techno geeks'
Jet may have turned; suspicious passengers checked
Man Raises Over $50,000 On Kickstarter To Publish Books...
This Cable Channel's Newest App Will Let You Watch...
Russian forces tighten control of Crimea
Boeing Dreamliner Makes Emergency Landing in Honolulu
9 website pioneers
Chilly Reception: Inside Quebec's Ice Hotel
Steve Ballmer: I Used To Be Painfully Shy (MSFT)
Technology Leads Week With 5 IPO filings; 5 More Added To Calendar
8 U.S. IPOs Planned For The Week
IPO Preview: Cempra Holdings
2 Life Sciences IPOs Debut Below Target
Caesars Stands Out In A Busy IPO Week With Strong Returns
Trius Therapeutics: The Calm Before The Storm
2012 Biotech IPOs: Age Of The Dreamers?
2 Promising Biopharma Companies To Examine
Stephen Brozak: Changing The Way Money Is Made And Diseases Are Cured
Companies That Can Mend The Biotech Market: Stephen Brozak
Cempra's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Cempra Management Discusses Toyama Exclusive Agreement Conference (Transcript)
Cempra's CEO Presents at BARDA Contract Award Conference (Transcript)
Can Cempra Beat The Superbugs?
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Cempra's CEO Discusses Q2 2013 Results - Earnings Call Transcript
Cempra's CEO Discusses Q3 2013 Results - Earnings Call Transcript
This Antibiotic Play May Be The Trius Of 2014
Cempra Holdings Hosts Solithromycin and Taksta Clinical Update Conference Call (Transcript)
Do Away With The Pill-A-Day Biotech Model: Steve Brozak
Cempra: Safety Results Solidifying Market Position
Cempra's CEO Discusses Q4 2013 Results - Earnings Call Transcript
This Cable Channel's Newest App Will Let You...
Malaysia Airlines Flight MH370 may have turned...
Create new account
Request new password
Click on the icon to sign in with your social network login or enter your Bullfax.com login
EUR/GBP: 1.205 USD/EUR: 1.3875 JPY/USD: 103.29
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions